Trinidad and Tobago Country Profile

Trinidad and Tobago Country Profile

Discover more about CDC’s work in Trinidad and Tobago by viewing our detailed country profilepdf icon

Country Overview

The CDC Caribbean Regional Office (CRO) opened in 2002 and is currently based in Jamaica. Trinidad and Tobago served as CDC CRO’s hub in 2002-2008. CDC CRO continues to support the Government of Trinidad and Tobago and other partners in-country to accelerate HIV epidemic control by: improving access to quality services for people living with HIV (PLHIV); re-engaging PLHIV lost to follow-up and retaining them on treatment to achieve viral suppression; enhancing laboratory capacity and viral load testing services; and improving data access and quality, particularly for key populations. CDC supports fast-tracking and adoption of international best practices and policies to continue advancing progress in the region.

Per Capita GNI

$15,410

(2020)

Population (million)

1.40

(2020)

Under 5 Mortality

18/1,000 Live Births

(2019)

Life Expectancy

74 Years

(2019)

Estimated HIV Prevalence

1.0%

(Ages 15-49) (2020)

Estimated AIDS Deaths

<500

(Age≥15) (2020)

TB Treatment Success Rate

64%

(2018)

Estimated TB Incidence

18/100,000

(2019)

TB Mortality (HIV Related)

1.5/100,000

(2019)

Estimated Orphans Due to AIDS

9,900

(2020)

TB patients with known HIV-status who are HIV-positive

16%

(2019)

Reported Number Receiving Antiretroviral Therapy (ART)

7,218

(Age≥15) (2020)


Strategic Focus

Since 2002, Centers for Disease Control and Prevention (CDC) has been committed to supporting the Rwandan Ministry of Health (MOH) to strengthen its capacity to prevent, detect and respond to public health threats through health workforce capacity building in the areas of; prevention of mother-to-child HIV transmission (PMTCT); HIV testing and counseling; antiretroviral therapy (ART); Tuberculosis (TB)/HIV integration; laboratory and blood safety; health informatics; surveillance; field epidemiology; and monitoring and evaluation.

 

Strengthening Clinical Services: CDC provides direct support and technical assistance (TA) to build expertise for MOH’s facility-based clinical services to provide comprehensive, integrated clinical HIV prevention and treatment. CDC also supports the scale-up of “one-stop” TB/HIV integrated services, offered at all 189 MOH Testing and Treatment Health Facilities.

Strengthening Laboratory Systems: CDC supports: laboratory workforce development; laboratory infrastructure improvement including regular equipment maintenance, laboratory information and specimen referral systems, implementation of laboratory quality management systems, EQA programs and quality improvement initiatives.  Support for disease surveillance includes HIV Recent infections. With this support, the National Reference Laboratory is working to meet international accreditation requirements and support the other laboratories attain local certification requirements. To enhance HIV program efficacy, CDC also supports strategies to reduce the turnaround time of core HIV test results, the use of laboratory informatics by clinicians and improve the laboratory clinical interface.

Strengthening HIV Prevention Activities: CDC provides MOH with financial support and TA in PMTCT, HIV Testing and Counselling, and HIV prevention among Key and Priority Populations and Voluntary Male Medical Circumcision (VMMC).

Strengthening Health Information Systems and Surveillance: CDC supports MOH in the innovative use of electronic health information systems to support the prevention, detection, treatment, and reporting of HIV. Using data from multiple electronic systems, a case-based surveillance system with a national unique patient identifier is being developed to improve understanding of HIV transmission, program performance and individual health outcomes.

Strengthening Science and Impact: CDC supports HIV surveillance surveys, program evaluations and impact assessments. The focus is to strengthen the capacity of implementing partners to measure progress toward epidemic control; to assess impact; to use data for program improvement; and to maintain scientific integrity. 

Enhancing Epidemiological Capacities: Through the Field Epidemiology Training Program (FETP), CDC has supported four cohorts for a total of 59 trainees in advanced FETP and over 430 frontline health workers in public health surveillance and emergency response. CDC also supports the MOH to develop a self-sustaining institutionalized capacity for competency building in epidemiology.

Key Activities and Accomplishments

Clinical Services: CDC has helped strengthen the scope, quality, and sustainability of ART services in Rwanda. In 2016 Rwanda effected a national roll out of “Treat All” and the new Differentiated Service Delivery Model (DSDM) for HIV treatment. In 2017, Rwanda implemented a monitoring and evaluation plan for DSDM to identify challenges and guide further programmatic changes and focus. In 2017, MOH also rolled out index testing with partner notification to increase HIV case detection.

 

TB/HIV Treatment: PLHIV on ART are routinely screened for TB disease, and achieved 87% TB treatment success rate in 2015. All health facilities that offer TB services provide directly observed TB treatment (DOT).

PMTCT: In Fiscal Year (FY) 2017 96% of health care facilities provided PMTCT services. Of pregnant women attending antenatal care, 99% accepted an HIV test (MOH National HIV Report 2017). HIV National Report shows the mother to child HIV transmission rate at 18 months continues to drop from 1.76% in 2016 to the current 1.51%, one of the lowest in Africa.

Laboratory Systems: Rwanda’s National Center for Blood Transfusion was awarded the highest, level 3, international standards accreditation, and is now a regional center of excellence in blood banking and is providing technical expertise to centers in the region. Rwanda is recognized by PEPFAR with the best achievements in meeting needed viral load capability

Key Populations Survey: In 2017, CDC is supporting size estimation surveys for both commercial sex workers and men who have sex with men (MSM). Results from these studies will have a major impact on the national testing strategies for both KPs.


Social Media Cardimage icon

CDC’s innovative efforts to Find, Cure, and Prevent TB are creating a safer America and a safer world.

image icon

Combating the Global TB Epidemic

Despite being preventable and treatable, tuberculosis (TB) is now the leading infectious disease killer in the world, taking the lives of 1.6 million people each year.

PEPFAR15 – Saving lives through American generosity and partnerships

For fifteen years, CDC has played a critical role in PEPFAR’s efforts to save millions of lives and transform the global HIV/AIDS response

Page last reviewed: September 30, 2021, 12:00 AM